Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Rubius Therapeutics, Inc. | 20,984 | reported | 31 Jan 2023 | tx 13+712,751−28,611 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 31 Jan 2023 | SALE | Rubius Therapeutics, Inc. | 2,593 | 0.24 USD | |
| 29 Jan 2023 | EXERCISE | Rubius Therapeutics, Inc. | 7,438 | — | |
| 31 Jan 2023 | EXERCISE | Rubius Therapeutics, Inc. | 8,625 | — | |
| 31 Jan 2023 | EXERCISE | Rubius Therapeutics, Inc. | 8,625 | 0.00 USD | deriv |
| 29 Jan 2023 | EXERCISE | Rubius Therapeutics, Inc. | 7,438 | 0.00 USD | deriv |
| 29 Jan 2022 | EXERCISE | Rubius Therapeutics, Inc. | 7,438 | — | |
| 01 Feb 2022 | SALE | Rubius Therapeutics, Inc. | 2,517 | 6.57 USD | |
| 31 Jan 2022 | GRANT_AWARD | Rubius Therapeutics, Inc. | 34,500 | 0.00 USD | deriv |
| 31 Jan 2022 | GRANT_AWARD | Rubius Therapeutics, Inc. | 143,750 | 0.00 USD | deriv |
| 29 Jan 2022 | EXERCISE | Rubius Therapeutics, Inc. | 7,438 | 0.00 USD | deriv |
| 29 Jan 2021 | GRANT_AWARD | Rubius Therapeutics, Inc. | 29,750 | 0.00 USD | deriv |
| 29 Jan 2021 | GRANT_AWARD | Rubius Therapeutics, Inc. | 131,250 | 0.00 USD | deriv |
| 31 Jan 2020 | GRANT_AWARD | Rubius Therapeutics, Inc. | 350,000 | 0.00 USD | deriv |